Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    PetIQ Inc (PETQ) Insider Trading Activity

    Healthcare • Drug Manufacturers - Specialty & Generic • 1,121 employees

    PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho. As of October 25, 2024, PetIQ, Inc. was taken private.

    Total Value

    -$81,040,576.56

    Total Shares

    -2,418,886

    Average Trade Value

    -$4,052,028.83

    Most Active Insider

    First Mark L

    Total Activity: $61,041,857

    Largest Single Transaction

    $61,010,857

    by First Mark L on Oct 25, 2024

    30-Day Activity

    0 Transactions

    Volume: 0 shares
    Value: $0

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    Evp, Services Manufactured
    Officer
    Oct 25, 2024 8,269 $203 0 Sale to Issuer
    Evp, General Counsel
    Officer
    Oct 25, 2024 3,497 $31,000 0 Sale to Issuer
    Director
    Oct 25, 2024 12,807 $31,000 0 Sale to Issuer
    Director
    Oct 25, 2024 14,822 $31,000 0 Sale to Issuer
    EVP Manufacturing Sup. Chain
    Officer
    Oct 25, 2024 10,481 $324,901 0 Sale to Issuer
    Director
    Oct 25, 2024 13,363 $31,000 0 Sale to Issuer
    Chief Executive Officer
    Director, Officer
    Oct 25, 2024 114,027 $8,049,991 0 Sale to Issuer
    Director
    Oct 25, 2024 1,972,687 $61,010,857 0 Sale to Issuer
    Director
    Oct 25, 2024 14,822 $31,000 0 Sale to Issuer
    President COO
    Officer
    Oct 25, 2024 88,808 $2,500,008 0 Sale to Issuer
    Director
    Oct 25, 2024 6,077 $31,000 0 Sale to Issuer
    Chief Executive Officer
    Director, Officer
    Oct 25, 2024 145,675 $8,042,011 0 Sale to Issuer
    EVP Manufacturing Sup. Chain
    Officer
    Oct 25, 2024 178 $324,901 0 Sale to Issuer
    Chief Financial Officer
    Officer
    Oct 25, 2024 9,800 $31,000 0 Sale to Issuer
    Chief Financial Officer
    Officer
    Oct 25, 2024 16,000 $31,000 0 Sale to Issuer
    Director
    Oct 25, 2024 18,547 $31,000 0 Sale to Issuer
    Evp, General Counsel
    Aug 28, 2024 5,000 $10,000 5,000 (+100.0%) Exercise/Conversion
    Evp, General Counsel
    Aug 28, 2024 1,503 $45,811 3,497 (-43.0%) Payment of Exercise Price
    President COO
    Aug 5, 2024 22,523 $482,893 97,808 (-23.0%) Payment of Exercise Price
    President COO
    Aug 5, 2024 50,000 $10,000 120,331 (+41.6%) Exercise/Conversion